Clinical Trial Update: Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II) [NA]

View source ↗

Summary

A clinical trial update on Thymosin alpha-1 for protection against immune dysregulation and organ dysfunction after acute aortic dissection surgery (PANDA II); …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Dissection Stanford Type
• Aortic Syndrome

Drugs mentioned

• Thymosin alpha-1 (thymosin alpha-1)

Snippet

Sponsor: Nanjing Medical University | Conditions: Acute Aortic Syndrome, Aortic Dissection Type a | NA | Status: RECRUITING